Analyzing CT images to assess metabolic complications in adrenal cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on analyzing existing CT images of patients with adrenal tumors to assess metabolic complications associated with the condition. Participating centers will identify eligible patients who have undergone adrenectomy or have benign adrenal tumors, and will send pseudonymized DICOM format images to a central coordinating center for radiomics analysis. The study ensures patient anonymity and data security throughout the process, with images accessible only to authorized personnel. The findings aim to enhance understanding of metabolic issues linked to adrenal tumors without impacting patient care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years
* Patients with adrenal tumor who underwent adrenectomy surgery from 1-1-2000 to 30-5-2023, performed according to clinical necessity and indications of international guidelines,with availability of histologic diagnosis or adrenal tumor that did not undergo adrenectomy surgery with diagnosis of benignity confirmed by radiologic stability at 6-12 months after first finding(as indicated in guidelines)
* Availability of radiological images in DICOM format of abdominal CT scan in which the adrenal tumor is first described, obtained on the date of first evaluation at the participating center (necessarily before surgery for patients undergoing adrenectomy)
* Signature of informed consent

Exclusion Criteria:

* none

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Guido Di Dalmazi, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Guido Di Dalmazi, MD
• Email: guido.didalmazi@unibo.it
• Phone: +390512143009

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Combining PD-1 inhibitor with Apatinib and Mitotane for advanced adrenal cancer treatment

  This study is testing a new combination of three medications to see if it can help people with advanced adrenal cancer who haven't had treatment yet.

  Recruiting Phase 2 West China Hospital · Chengdu, Sichuan · NCT06831175

• Using Ivocizumab to treat various advanced rare tumors

  This study is testing if a new treatment called Ivocizumab can help people with different types of advanced rare tumors feel better and live longer.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT06683846

• Combining PDS01ADC with targeted liver chemotherapy for certain cancers

  This study is testing if a new cancer treatment that combines an immune booster with targeted liver chemotherapy can help people with certain advanced cancers feel better and live longer.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT05286814

• Adrenal Function in RA Patients on Low-Dose Corticosteroids

  This study tests how common adrenal insufficiency is among rheumatoid arthritis patients who are taking low-dose corticosteroids.

  Recruiting Bursa Yuksek Ihtisas Training and Research Hospital · Bursa, Yıldırım · NCT07866326

• Normal ranges and diagnostic cut-offs for salivary cortisol

  This project will test two saliva cortisol methods — a lab LC‑MS assay and a rapid fluorescence immunoassay — to find normal ranges and the best diagnostic cut-offs for adults with suspected Cushing syndrome or adrenal insufficiency.

  Recruiting Shanghai 6th People's Hospital · Shanghai, Shanghai Municipality · NCT07168122

• Evaluating adrenal insufficiency after surgery in patients with primary aldosteronism

  This study is testing how often people with primary aldosteronism develop adrenal insufficiency after having surgery to remove their adrenal glands.

  Recruiting Chongqing Medical University · Chongqing, Chongqing Municipality · NCT06955286

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.